Oasis500 invests in Pi Pharma Intelligence
InvestmentsPi Pharma Intelligence joined the Oasis500 portfolio of companies Pi Pharma Intelligence has received a seed investment from Oasis500. This investment will be utilized to enable the commercial launch of the company in the region and finalizing the company HR structure needed for the short term objectives. Pi Pharma Intelligence is grateful for the trust of Oasis500 on its vision and assets.
Pi Pharma Intelligence attended dealmakers 2022
Nov, 2022
Pi Pharma Intelligence attended dealmakers 2022
Dr Nimer Alkhatib will present “Biosimilars Utilization and Uptake in the Market” study in Jordan FDA Third international Conference on Pharmaceuticals
Jun, 2023
Dr Nimer Alkhatib will present “Biosimilars Utilization and Uptake in the Market” study in Jordan FDA Third international Conference on Pharmaceuticals
Strengthening Communication Skills at PI Pharma!
Aug, 2024
Effective communication is essential for success in our industry, and this training will equip our employees with advanced skills to enhance their interactions and drive better results.